Left ventricular remodeling after the first myocardial infarction in association with LGALS-3 neighbouring variants rs2274273 and rs17128183 and its relative mRNA expression: a prospective study.
Ana DjordjevicMilica DeklevaMaja ZivkovicAleksandra StankovicNatasa Markovic NikolicDragan AlavanticTamara DjuricPublished in: Molecular biology reports (2018)
Post-infarct left ventricular remodeling (LVR) process increases the risk of heart failure (HF). Circulating galectin-3 has been associated with fibrosis, inflammation and cardiac dysfunction during the remodeling process after myocardial infarction (MI). The aims of this prospective case study were to investigate the association of potentially functional variants in the vicinity of LGALS-3 locus, rs2274273 and rs17128183 with maladaptive LVR and whether these variants could affect LGALS-3 mRNA expression in peripheral blood mononuclear cells of patients 6 months after the first MI. This study encompassed 167 patients with acute MI that were followed up for 6 months. Evidence of LVR was obtained by repeated 2D Doppler echocardiography. Rs2274273, rs17128183 and LGALS-3 mRNA expression were detected by TaqMan® technology. Rs2274273 and rs17128183 rare allele bearing genotypes, according to the dominant model (CT+TT vs. CC and AG+GG vs. AA, respectively), were significantly and independently associated with maladaptive LVR (adjusted OR = 3.02, P = 0.016; adjusted OR = 3.14, P = 0.019, respectively) and higher LGALS-3 mRNA expression (fold induction 1.203, P = 0.03 and 1.214, P = 0.03, respectively). Our exploratory results suggest that rs2274273 and rs17128183 variants affect LGALS-3 mRNA and bear the risk for maladaptive LVR post-MI remodeling. Further replication and validation in a larger group of patients is inevitable.
Keyphrases
- left ventricular
- heart failure
- end stage renal disease
- ejection fraction
- computed tomography
- oxidative stress
- acute myocardial infarction
- chronic kidney disease
- prognostic factors
- coronary artery disease
- dna methylation
- cardiac resynchronization therapy
- acute coronary syndrome
- hypertrophic cardiomyopathy
- gene expression
- pulmonary hypertension
- aortic valve
- contrast enhanced
- positron emission tomography
- quantum dots
- patient reported
- image quality
- liver fibrosis
- dual energy